To seek long-term investment growth, through growth of capital. The Fund mainly invests in equities of healthcare-related companies (companies that operate in, or are related to, the major subsectors of the healthcare sector, including pharmaceuticals, biotechnology, healthcare technology, life sciences tools and services, healthcare equipment and supplies, and healthcare providers and services).

The Fund promotes environmental and/or social characteristics in accordance with Article 8 of the Sustainable Finance Disclosure Regulation (the “SFDR”). 

In its implementation of the Fund’s Environmental, Social and Governance (ESG) strategy, the Investment Manager integrates consideration of financially material ESG issues in the fundamental research process, such as social issues including workforce engagement, diversity and inclusion; employee well-being, development and opportunity; product impact and customer well-being; pricing philosophy and access; and governance issues such as board structure and composition, risk management and leadership.

The Investment Manager considers ESG analysis as additive and complementary to the fundamental understanding that is at the center of its investment philosophy. Relevant issues are considered within the operating context of an issuer. The Investment Manager’s ESG and sustainability research is guided by its internally developed materiality map which was inspired and guided by the materiality mapping of the Sustainable Accounting Standards Board (SASB) / the International Sustainability Standards Board (ISSB). The Investment Manager also uses third-party data to augment the investment process in terms of measuring and reporting. While the Investment Manager does not rely solely on third-party scoring, it uses these inputs as part of the overall research analysis. 

As part of its investment decision making process, the Fund’s ESG strategy also uses binding criteria for the selection of underlying assets and applies specific ESG exclusions.

Please click here for more information.

The Fund does not offer any capital guarantee or protection and you may not get back the amount invested.

• The Fund is subject to the following risks which are materially relevant:
  Investment in company shares: The fund invests in shares of companies, and the value of these shares can be negatively affected by changes in the company, its industry or the economy in which it operates.
  Fund operations: The fund is subject to the risk of loss resulting from inadequate or failed internal processes, people or systems or those of third parties such as those responsible for the custody of its assets, especially to the extent that it invests in developing countries.
  Sustainability: The fund's integration of sustainability risks in the investment decision process may have the effect of excluding profitable investments from the investment universe of the fund and may also cause the fund to sell investments that will continue to perform well. A sustainability risk could materialise due to an environmental, social or governance event or condition which may impact the fund's investments and negatively affect the returns of the fund.
  Concentrated fund: The fund invests in fewer companies than other funds which invest in shares usually do. This means that the fund does not spread its risk as widely as other funds and will therefore be affected more if an individual company has significant losses.
  Emerging markets investment: The fund may invest in the markets of countries which are smaller, less developed and regulated, and more volatile than the markets of more developed countries.
  Derivatives: The use of derivatives can result in greater fluctuations of the fund's value and may cause the fund to lose as much as or more than the amount invested.

Complete information on the risks of investing in the Fund are set out in the Fund's prospectus.